EPIDYOLEX

Serial Number 79330763
Registration 6976395
700

Registration Progress

Application Filed
Jun 23, 2021
Under Examination
Approved for Publication
Nov 29, 2022
Published for Opposition
Nov 29, 2022
Registered
Feb 14, 2023

Basic Information

Serial Number
79330763
Registration Number
6976395
Filing Date
June 23, 2021
Registration Date
February 14, 2023
Published for Opposition
November 29, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 14, 2023
Registration
Registered
Classes
041 042 044

Rights Holder

Jazz Pharmaceuticals Research UK Limited

98
Address
Building 730,
Kent Science Park Sittingbourne, Kent ME9 8AG
GB

Ownership History

GW Research Ltd

Original Applicant
99
GB

GW Research Ltd

Owner at Publication
99
GB

GW Research Ltd

Original Registrant
99
GB

Jazz Pharmaceuticals Research UK Limited

New Owner After Registration #1
98
GB

Legal Representation

Attorney
Michael T. Olsen

USPTO Deadlines

Next Renewal Deadline
1318 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-02-14)
Due Date
February 14, 2029
Grace Period Ends
August 14, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description
Jan 30, 2025 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 13, 2023 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
May 17, 2023 FICS P FINAL DISPOSITION NOTICE SENT TO IB
May 17, 2023 FIMP P FINAL DISPOSITION PROCESSED
May 14, 2023 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 14, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER
Feb 14, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 12, 2022 GPNX P NOTIFICATION PROCESSED BY IB
Nov 29, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 29, 2022 PUBO A PUBLISHED FOR OPPOSITION
Nov 23, 2022 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 23, 2022 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 9, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 26, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 13, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 12, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 12, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 25, 2022 RFNT P REFUSAL PROCESSED BY IB
Apr 29, 2022 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 28, 2022 RFRR P REFUSAL PROCESSED BY MPU
Apr 1, 2022 NREP P NEW REPRESENTATIVE AT IB RECEIVED
Mar 18, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 17, 2022 CNRT R NON-FINAL ACTION WRITTEN
Mar 15, 2022 DOCK D ASSIGNED TO EXAMINER
Feb 1, 2022 MAFR O APPLICATION FILING RECEIPT MAILED
Jan 27, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 20, 2022 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 6, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 041
Educational services namely, providing and conducting classes, seminars, symposiums, conferences and workshops in the field of pharmaceutical product development of medicines, healthcare, and cancer treatment; instruction and training services, in the field of pharmaceutical product development of medicines and cancer treatments; education services relating to medicine, namely, providing and conducting classes, seminars, symposiums, conferences and workshops in the field of pharmaceutical product development of medicines, healthcare, and cancer treatment; organising and conducting seminars and conventions in the field of medicine; information, advisory and consultancy services in relation to all of the aforesaid services
Class 042
Scientific and technological services, namely, scientific research, analysis, testing in the field of medicines, healthcare, and cancer treatment, and research and design relating thereto; chemical analysis; chemical research; research and development of new products for others; research and development on the subject of pharmaceuticals; consultancy relating to pharmaceutical research and development; conducting clinical trials in the field of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; information, advisory and consultancy services in relation to all of the aforesaid services
Class 044
Medical services, veterinary services, medical analysis services; pharmaceutical services; pharmaceutical advisory services; provision of pharmaceutical information; providing information in the field of medicine; horticultural services; information, advisory and consultancy services in relation to all of the aforesaid services

Classification

International Classes
041 042 044